MRI plus CT does not reliably predict nonviability of disappearing colorectal liver metastases, a new study reports.
This prospective study included 135 patients (median age, 67 years; 66 women) who underwent MRI-guided SBRT for liver metastases across seven international centres between April 2019 and April 2023.
Equity host Rebecca Bellan catches up with Chipiron CEO and co-founder Evan Kervella about the future of MRI technology.ec ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback